Registration has now opened for Oxford Global’s 17th Annual Drug Discovery Leaders Summit
Posted: 13 January 2016 | Oxford Global | No comments yet
Oxford Global Conferences are proud to present the successful 17th Annual Drug Discovery Leaders Summit and co-located 4th Annual Discovery Chemistry & Drug Design Congress taking place on the 13th & 14th June in Berlin…
Oxford Global Conferences are proud to present the successful 17th Annual Drug Discovery Leaders Summit and co-located 4th Annual Discovery Chemistry & Drug Design Congress taking place on the 13th & 14th June in Berlin. Over 250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will have the opportunity to discuss over 55 presentations, case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry.
Attend this meeting to take part in high level scientific discussions on the hottest topics in the industry. Our Congress will cover 9 interactive streams:
Drug Discovery Summit:
- Key Discovery Strategies: Target Based Discovery and Phenotypic Screening
- Screening & Assays: Enabling Technologies
- Supporting Innovation: Data & Information Management
- Discovery Chemistry: Latest Case Studies
- Drug Design: Novel Approaches
- Large Molecule Drug Discovery: Immuno-oncology & Cell Therapies
- Novel Therapeutic Modalities: Natural Products, the Microbiome and CRISPR
Discovery Chemistry & Drug Design:
- Discovery Chemistry: Latest Case Studies
- Drug Design: Novel Approaches
Who will be speaking?
- Tove Tuntland, Director Of Metabolism And Pharmacokinetics (MAP), Genomics Institute Of Novartis Research Foundation (GNF)
- Peter Dandliker, Director, ALIS Affinity Screening, Merck
- Thomas Steger-Hartmann, Head of Investigational Toxicology, Vice President, Bayer HealthCare
- Anil Nair, Head Of In Silico Drug Discovery, Sanofi-Aventis
- Ulrich Betz, Senior Director, Department Head Innovation & Entrepreneurship, Merck
- Guido Hanaeur, Scientific Director Translational Medicine, TAKEDA Pharmaceuticals
Click here to review the full Agenda: http://www.drugdiscovery-summit1.com/download-agenda-marketing/
Reduce preclinical failures with smarter off-target profiling
24 September 2025 | 15:00PM BST | FREE Webinar
Join this webinar to hear from Dr Emilie Desfosses as she shares insights into how in vitro and in silico methods can support more informed, human-relevant safety decisions -especially as ethical and regulatory changes continue to reshape preclinical research.
What you’ll learn:
- Approaches for prioritizing follow-up studies and refining risk mitigation strategies
- How to interpret hit profiles from binding and functional assays
- Strategies for identifying organ systems at risk based on target activity modulation
- How to use visualization tools to assess safety margins and compare compound profiles
Register Now – It’s Free!
What is included in your place?
- Full access to the 2 days of conference presentations
- Free access to the co-located 4th Annual Discovery Chemistry & Drug Design Congress
- Lunch and Refreshments during the congress
- Access to all networking activities
- Access to exhibition area
- Conference workbook and online access to conference materials, notes and presentations
Reserve Your Place Today!
Registration to attend the Genetics in Forensics is now open. For further information on booking your place today, or to find out more regarding available Early Bird Discounts along with a small number of group discounts, please contact Guillaume Alonso on [email protected] or call +44 (0)1865 248455 to request further information regarding the Congress or to receive a promotional code.
You can also discover even more and discuss the latest topics in drug discovery and medicinal chemistry on our social media:
Twitter: https://twitter.com/drugdiscovery1
LinkedIn: Drug Discovery & Development Network Group
Related topics
Cell-based assays, Drug Discovery, Genomics, Immuno-oncology, Screening
Related organisations
Oxford Global
